Актуальность. Эра ингибиторов тирозинкиназ (ИТК) ознаменовалась долгосрочным
благоприятным прогнозом хронического миелолейкоза (ХМЛ). В такой ситуации у …

Objective: To explore the pregnancy outcome and disease status among patients with
chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitor (TKI) when they …

Background: Atypical chronic myeloid leukemia was first depicted as a subtype of myeloid
neoplasm that closely resembles chronic myeloid leukemia but does not have the …

Improvement in cancer treatments has allowed more women to plan a pregnancy once the
disease is cured. The effects of chemotherapy on ovaries are well proven but those on the …

I have read with interest the paper by Law et al.[1], in which the authors shared their
experience on the management of chronic myeloid leukemia (CML) in pregnancy …

Background: Imatinib Mesylate (IM), the first tyrosine kinase inhibitor recommended for the
treatment of Chronic Myeloid Leukemia (CML) patients with presence of Philadelphia …

Leukemia is one of the most common types of cancer in young people, with 5-year survival
rates ranging from 54% to 94%. Due to gonadotoxic treatment, the chances of subsequent …

Acute leukemias commonly diagnosed in pregnancy include acute myeloid leukemia, acute
promyelocytic leukemia, and acute lymphoblastic leukemia. These are aggressive diseases …

Cancer affects around 1 in 1000 pregnancies; hematological malignancies represent a
small portion of malignant diseases, and therefore cases of leukemia during gestation are …

Wprowadzenie inhibitorów kinaz tyrozynowych (TKI) do leczenia chorych na przewlekłą
białaczką szpikową (CML) spowodowało znaczną poprawę rokowania. W ostatnich latach …